{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-056448","form_type":"8-K","ticker":"TWST","cik":"0001581280","company_name":"Twist Bioscience Corp","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.308205+00:00","generated_at":"2026-06-25T23:41:34.730446+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Twist Bioscience Q2 revenue $48.1M (+54% YoY), orders $55.0M (+32% YoY)","bullets":["Record revenue $48.1M, up 54% YoY from $31.2M.","Net loss $60.7M ($1.13/share) vs $37.9M ($0.78) prior year.","Orders $55.0M, up 32% YoY from $41.7M.","Four-year supply agreement with Ginkgo Bioworks, $58M minimum purchases over contract term.","Cash $604.4M; raised $269.8M net from public offering completed in the quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-056448","json":"https://secwatch.observer/filing/0001104659-22-056448.json","markdown":"https://secwatch.observer/filing/0001104659-22-056448.md","text":"https://secwatch.observer/filing/0001104659-22-056448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581280/000110465922056448/0001104659-22-056448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581280/000110465922056448/tm2214535d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:41:34.730446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}